Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects

Recently, the use of nebulized antibiotics in the intensive care unit, in particular amikacin, has been the subject of much discussion, owing to unconvincing results from the latest randomized clinical trials....
Source: Critical Care - Category: Intensive Care Authors: Tags: Review Source Type: research